Search
for
Sort by
Research 121–150 of 1000+
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- Dermatologic Changes in Experimental Model of Long COVID
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Dermatological Manifestations of COVID-19 in Children
- The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Post-COVID Telogen Effluvium.
- Coronavirus Infection and Cholesterol Metabolism
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Comprehensive Review of Perilla frutescens: Chemical Composition, Pharmacological Mechanisms, and Industrial Applications in Food and Health Products
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19